The USACE Los Angeles District issued a solicitation for a construction support contract, which will be a total small ...

As of February 28, 2025, 99 patients were enrolled (Phase 1a, n=8; Phase 1b, n=6, Phase 2, n=30, 25, and 30 in Cohorts A, B, and C, respectively). The baseline characteristics are summarized below: ...

The Public Investment Fund (PIF) announced today, June 19, the launch of Expo 2030 Riyadh Co. (ERC), a wholly owned subsidiary tasked with developing ...

Dr. Baldini concluded her presentation discussing phase 1 results of JNJ-78278343 (pasritamig) in mCRPC with the following take home points: Pasritamig was very well tolerated (<10% of patients ...

We conducted a multicohort, open-label, phase 1/2 trial (CC-220-MM-001) at 42 treatment centres in Europe, Canada, and the USA. Patients aged 18 years or older with multiple myeloma who had received ...

The first patient has been dosed in a phase 1 trial (NCT06801236) investigating the novel CYP11A1 inhibitor ACE-232 in patients with metastatic castration-resistant prostate cancer (mCRPC), Acerand ...

Nurix Therapeutics will host a webcast on June 12, 2025, to discuss Phase 1 trial data for bexobrutideg. Quiver AI Summary. Nurix Therapeutics, Inc. has announced a webcast conference call ...

Following the initial release at I/O 2025 two weeks ago, Google is rolling out Android 16 QPR1 Beta 1.1 as a bug fixer for Pixel devices. BP31.250502.008.A1 with the May 2025 security patch is ...

Phase 1 1 First-In-Human study designed to assess safety, tolerability, right dose for Phase 2 and early signs of efficacy of 177Lu-RAD202 in individuals with advanced HER2-positive solid tumors.

ABC's '9-1-1: Nashville has added Hailey Kilgore, Michael Provost, Juani Feliz and Hunter McVey in series regular roles.

BOSTON, June 3, 2025 /PRNewswire/ -- Boston-based Cybernetix Ventures, a leading US early-stage venture capital firm investing in robotics, automation and physical AI technology companies, today ...